← United States · Coverage record
US · SEC FORM 4
Charlotte's Web Holdings, Inc.
CWBHF · OTC · CIK 0001750155 · Consumer Defensive · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
1 buyers · 1 purchase transaction lines · $40.0K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ✓ Role scores high · most senior buyer: Chief Operating Officer
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Chief Operating Officer. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 44.7
- 44.6
- 44.4
- 44.3
- 44.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -18.0%
- 3M
- +0.0%
- 6M
- -54.2%
- 12M
- +51.4%
Volatility & liquidity
- Volatility
- 121.5%
- Beta
- —
- Avg daily value
- USD 60,385
Valuation
- Market cap
- USD 72.7M
- P/E
- —
Fundamentals
- Profit margin
- -59.6%
- ROE
- —
- Industry
- Drug Manufacturers—Specialty & Generic
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-11 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 295,763
- Previous report
- 353,854
- Avg daily volume
- 194,583
- Days to cover
- 1.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Kunkel Raymond J. | Purchase (P) | Common Shares | 137,935 | USD 0.29 | USD 40,001 | SEC filing ↗ |
| 2025-09-02 | Kunkel Raymond J. | Purchase (P) | Common Shares | 229,167 | USD 0.10 | USD 22,917 | SEC filing ↗ |
| 2025-05-30 | Kunkel Raymond J. | Purchase (P) | Common Shares | 227,273 | USD 0.11 | USD 24,863 | SEC filing ↗ |
| 2024-09-03 | Kunkel Raymond J. | Purchase (P) | Common Shares | 125,167 | USD 0.15 | USD 18,775 | SEC filing ↗ |
| 2024-08-30 | Kunkel Raymond J. | Purchase (P) | Common Shares | 2,479 | USD 0.14 | USD 347 | SEC filing ↗ |
| 2024-08-29 | Kunkel Raymond J. | Purchase (P) | Common Shares | 8,100 | USD 0.14 | USD 1,134 | SEC filing ↗ |
| 2024-08-28 | Kunkel Raymond J. | Purchase (P) | Common Shares | 10,000 | USD 0.14 | USD 1,400 | SEC filing ↗ |
| 2024-08-27 | Kunkel Raymond J. | Purchase (P) | Common Shares | 2,000 | USD 0.14 | USD 280 | SEC filing ↗ |
Form 4 evidence
26 transaction lines in the latest 365-day window; 151 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 294,662 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-10-01 | Morachnick William J. | Tax withholding (F) | Common Shares | 71,751 | USD 0.28 | USD 20,112 | SEC filing ↗ |
| 2026-09-30 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (24 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 294,662 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-10-01 | Morachnick William J. | Tax withholding (F) | Common Shares | 71,751 | USD 0.28 | USD 20,112 | SEC filing ↗ |
| 2026-09-30 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-30 | Morachnick William J. | Tax withholding (F) | Common Shares | 91,313 | USD 0.27 | USD 24,700 | SEC filing ↗ |
| 2026-09-03 | Kunkel Raymond J. | Purchase (P) | Common Shares | 137,935 | USD 0.29 | USD 40,001 | SEC filing ↗ |
| 2026-07-01 | Usifer Maureen K | Option exercise / conversion (M) | Common Shares | 75,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-01 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 294,661 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-01 | Morachnick William J. | Tax withholding (F) | Common Shares | 71,750 | USD 0.31 | USD 22,242 | SEC filing ↗ |
| 2026-07-01 | McElwee Angela May | Option exercise / conversion (M) | Common Shares | 85,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-01 | McCarthy Matthew Evan | Option exercise / conversion (M) | Common Shares | 75,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-30 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-30 | Morachnick William J. | Tax withholding (F) | Common Shares | 91,313 | USD 0.31 | USD 28,307 | SEC filing ↗ |
| 2026-05-28 | BT DE Investments Inc.; British American Tobacco p.l.c. | C (C) | Common Shares | 95,281,277 | USD 0.68 | USD 64,791,268 | SEC filing ↗ |
| 2026-05-28 | BT DE Investments Inc.; British American Tobacco p.l.c. | Award / grant (A) | Common Shares | 14,662,765 | USD 0.68 | USD 9,970,680 | SEC filing ↗ |
| 2026-04-01 | Stanley Jared | Option exercise / conversion (M) | Common Shares | 37,178 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Stanley Jared | Tax withholding (F) | Common Shares | 12,659 | USD 0.78 | USD 9,874 | SEC filing ↗ |
| 2026-04-01 | Lind Erika | Option exercise / conversion (M) | Common Shares | 71,594 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Lind Erika | Tax withholding (F) | Common Shares | 21,773 | USD 0.78 | USD 16,983 | SEC filing ↗ |
| 2026-04-01 | Kunkel Raymond J. | Option exercise / conversion (M) | Common Shares | 88,916 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Kunkel Raymond J. | Tax withholding (F) | Common Shares | 25,565 | USD 0.78 | USD 19,941 | SEC filing ↗ |
| 2025-12-31 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-31 | Morachnick William J. | Option exercise / conversion (M) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-31 | Morachnick William J. | Tax withholding (F) | Common Shares | 111,188 | USD 0.37 | USD 41,140 | SEC filing ↗ |
| 2025-12-31 | Morachnick William J. | Tax withholding (F) | Common Shares | 91,313 | USD 0.37 | USD 33,786 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | CWBHF |
| CIK | 0001750155 |
| Sector | Consumer Defensive |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 0100 Agricultural Production-Crops |
| Exchange | OTC |
Data coverage
| Local Form 4 history | 151 transaction lines from 2022-01-09 to 2026-10-01 10 P purchase lines · 1 S sale lines · 140 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.